Phathom Pharmaceuticals
PHAT
PHAT
87 hedge funds and large institutions have $317M invested in Phathom Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 94 → 87 (-7)
9.25% less ownership
Funds ownership: 77.04% → 67.79% (-9.3%)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Holders
87
Holding in Top 10
3
Calls
$133K
Puts
$124K
Top Buyers
| 1 | +$4.68M | |
| 2 | +$1.89M | |
| 3 | +$1.7M | |
| 4 |
Walleye Capital
New York
|
+$1.64M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.57M |
Top Sellers
| 1 | -$26.8M | |
| 2 | -$3.52M | |
| 3 | -$1.71M | |
| 4 |
HF
HRT Financial
New York
|
-$585K |
| 5 |
Millennium Management
New York
|
-$558K |